Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 27, Issue 34, 2009, Pages 5823-5829

  Yoo, Seung Soo ^a   Choi, Jin Eun ^a   Lee, Won Kee ^a   Choi, Yi Young ^a   Kam, Sin ^a   Kim, Min Jung ^a   Jeon, Hyo Sung ^a   Lee, Eung Bae ^a   Kim, Dong Sun ^a   Lee, Myung Hoon ^a   Kim, In San ^a   Jheon, Sanghoon ^a   Park, Jae Yong ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE;

ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; GENETIC POLYMORPHISM; GENETICS; LUNG TUMOR; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; SURVIVAL RATE;

CARCINOMA, NON-SMALL-CELL LUNG; CASPASES; DISEASE-FREE SURVIVAL; FEMALE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 73349124805     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.1738     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55:74-108, 2005
2. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy for completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
3. Singhal S, Vachani A, Antin-Ozerkis D, et al: Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review. Clin Cancer Res 11:3974-3986, 2005
4. Thompson CB: Apoptosis is the pathogenesis and treatment of disease. Science 267:1456-1462, 1995
5. Raff M: Cell suicide for beginners. Nature 396:119-122, 1998
6. Lowe SW, Lin AW: Apoptosis in cancer. Carcinogenesis 21:485-495, 2000
7. Evan GI, Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348, 2001
8. Shivapurkar N, Reddy J, Chaudhary PM, et al: Apoptosis and lung cancer: A review. J Cell Biochem 88:885-898, 2003
9. Nicholson DW, Thornberry NA: Caspases: Killer proteases. Trends Biochem Sci 22:299-306, 1997
10. Budihardjo I, Oliver H, Lutter M, et al: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15:269-290, 1999
11. Degterev A, Boyce M, Yuan J: A decade of caspases. Oncogene 22:8543-8567, 2003
12. Fuentes-Prior P, Salvesen GS: The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 384:201-232, 2004
13. Sun T, Gao Y, Tan W, et al: A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 40:259-260, 2008
14. MacPherson G, Healey CS, Teare MD, et al: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96:1866-1869, 2004
15. Son JW, Kang HK, Chae MH, et al: Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 169:121-127, 2006
16. Li C, Zhao H, Hu Z, et al: Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Human Mutat 29:1443-1451, 2008
17. Park JY, Park JM, Jang JS, et al: Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet 15:1963-1971, 2006
18. Frank B, Hemminki K, Wappenschmidt B, et al: Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with CASP8 D302H variant. Carcinogenesis 27:606-609, 2006
19. Jang JS, Kim KM, Choi JE, et al: Identification of polymorphisms in the Caspase-3 gene and their association with lung cancer risk. Mol Carcinog 47:383-390, 2008
20. Lee WK, Kim JS, Kang H-G, et al: Polymorphisms in the caspase 7 gene and the risk of lung cancer. Lung Cancer 65:16-24, 2009
21. Brambilla E, Travis WD, Colby TV, et al: The new World Health Organization classification of lung tumors. Eur Respir J 18:1059-1068, 2001
22. Mountain CF: Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717, 1997
23. Stephens M, Smith MJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989, 2001
24. Rebbeck TR, Spitz M, Wu X: Assessing the function of genetic variants in candidate gene association studies. Nat Rev Genet 5:589-597, 2004
25. Sunyaev S, Ramensky V, Koch I, et al: Prediction of deleterious human alleles. Hum Mol Genet 10:591-597, 2001
26. Fernandes-Alnemri T, Takahashi A, Armstrong R, et al: Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 55: 6045-6052, 1995
27. García-Lozano JR, Torres B, Fernández G, et al: Caspase 7 influences susceptibility to rheumatoid arthritis. Rheumatol (Oxford) 46:1243-1247, 2007
28. Sekido Y, Fong KM, Minna JD: Molecular genetics of lung cancer. Annu Rev Med 54:73-87, 2003
29. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98:13790-13795, 2001
30. Sun Z, Yang P: Gene expression profiling on lung cancer outcome prediction: Present clinical value and future premise. Cancer Epidemiol Biomarkers Prev 15:2063-2068, 2006
31. Soini Y, Pakko P, Lehto VP: Histopathological evaluation of apoptosis in cancer. Am J Pathol 153:1041-1053, 1998
32. Törmänen-Näpänkangas U, Soini Y, Kahlos K, et al: Expression of caspases-3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int J Cancer 93:192-198, 2001
33. Park JY, Lee WK, Jung DK, et al: Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Clin Cancer Res 15:1794-1800, 2009
34. Chanock SJ, Manolio T, Boehnke M, et al: Replicating genotype-phenotype associations. Nature 447:655-660, 2007